Corcept Therapeutics Inc (CORT)

Corcept Therapeutics Inc Stock (CORT) Financials Data

*All numbers in millions

Period End Date	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	55.33%256.15	164.90	202.13	207.64	194.43
Cost Of Revenue	40.86%4.06	2.88	2.55	4.60	3.43
	7.94%156.90	145.36	130.24	-	-
Selling, General, and Administrative	7.94%156.90	145.36	130.24	-	-
Research and Development	18.68%53.89	66.27	64.86	-	-
Costs And Expenses	0.16%214.85	214.50	197.64	197.42	167.76
Operating Income/Loss	183.26%41.30	-49.60	4.49	10.22	26.68
Nonoperating Income/Loss	5.22%4.63	4.89	5.42	5.02	5.02
Income/Loss From Continuing Operations Before Tax	202.72%45.93	-44.72	9.91	15.24	31.69
Income Tax Expense/Benefit, Deferred	121.98%2.88	-13.11	-15.18	9.11	-17.76
Income Tax Expense/Benefit	122.73%2.94	-12.95	-14.38	-4.43	-3.46
	235.35%42.99	-31.76	24.29	19.67	35.15
Attributable To Parent	235.35%42.99	-31.76	24.29	19.67	35.15
Available To Common Stockholders, Basic	235.06%42.14	-31.20	23.90	19.36	34.61
Basic Average Shares	0.90%105.38	104.44	-	103.55	104.11
Diluted Average Shares	13.36%118.39	104.44	-	119.44	120.49
Basic Earnings Per Share	233.33%0.40	-0.30	-	0.19	0.33
Diluted Earnings Per Share	220.00%0.36	-0.30	-	0.16	0.29